By promoting transcription of survival-related and chemo-resistance-related genes while suppressing transcription of genes related to apoptotic-signaling, lncRNA-H19 is supposed to play a role in the chemotherapeutic resistance in HCC patients as well [14]. This evidence concerns the gene H19 and hepatocellular carcinoma.